Reversible renal failure due to bilateral renal sarcoma in a patient with acute myeloid leukemia.
A 68-year-old male presented with acute myeloid leukemia, renal failure, hypokalemia, and enlarged kidneys on renal ultrasound. Renal biopsy revealed massive leukemic infiltration of the kidney. After systemic chemotherapy, the patient developed tumor lysis syndrome followed by a phase of proximal tubule dysfunction presenting as polyuria and diverse electrolyte abnormalities. In time, renal function returned to normal, as did kidney size. This report shows that renal failure, enlargement of the kidneys, and tubule dysfunction in the course of AML infiltrating the kidneys can be reversed by treatment of the hematological disease.
Rüger
Wim
W
Department of Nephrology, Erasmus Medical Center, Rotterdam, The Netherlands. j.ruger@vumc.nl
Kruip
Marieke J H A
MJ
Betjes
Michiel G H
MG
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects; D001707:Biopsy, Needle; D005440:Fluid Therapy / Q000379:methods; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D007677:Kidney Function Tests; D007680:Kidney Neoplasms / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D017254:Leukemic Infiltration / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D008297:Male; D009367:Neoplasm Staging; D020127:Recovery of Function; D051437:Renal Insufficiency / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D018570:Risk Assessment; D012509:Sarcoma / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D016896:Treatment Outcome; D015275:Tumor Lysis Syndrome / Q000150:complications / Q000188:drug therapy / Q000209:etiology*